SANA - Sana Biotechnology, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.35 -0.38 (-5.98%) -0.02 (-0.33%) -0.05 (-0.83%) -0.21 (-3.4%) -0.38 (-5.98%) 1.41 (31.15%) -0.01 (-0.24%) 0.06 (1.02%)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-0.39
Diluted EPS:
-0.39
Basic P/E:
-15.3077
Diluted P/E:
-15.3077
RSI(14) 1m:
43.75
VWAP:
5.98
RVol:
0.0534

Events

Period Kind Movement Occurred At
1m Price increase 1m 5.84 +0.11 (+1.92%) Oct 15 16:17
1m Price increase 1m 5.84 +0.11 (+1.92%) Oct 15 16:17
1m Price increase 1m 5.84 +0.11 (+1.92%) Oct 15 16:17
1m Price increase 1m 5.84 +0.11 (+1.92%) Oct 15 16:17
1m Price increase 1m 5.84 +0.11 (+1.92%) Oct 15 16:17

Related News